Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation Inhibition of EE/GSD Transdermal Patches
NCT00729404Phase 2Terminated
- Sponsor
- Bayer
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethinyl estradiol + gestodene in contraception, sponsored by Bayer. Started Aug 2008; status: terminated.
02
Drugs
ethinyl estradiol + gestodene
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00729404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729404.